China’s export control regime on rare earths isn’t retaliation for recent US restrictions – it’s a response to overall US policy

China’s export control regime on rare earths isn’t retaliation for recent US restrictions – it’s a response to overall US ...

SciSparc-Clearmind Collaboration Leads to Publication of U.S. Patent Application Targeting Binge Behavior Disorders

SciSparc-Clearmind collaboration, focusing on PEA-MEAI combinations for conditions such as alcohol use disorder, cocaine ...
The Manila Times

Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ('Clearmind” or the 'Company'), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...